GLP-1 & Metabolic Products Guide
GLP-1-related products are among the most frequently confused listings online. This guide explains the terminology, the difference between an approved medicine and an unapproved or compounded product, the importance of source and labeling, and the questions a careful reader should ask.
This page does not provide medical advice, prescribing, dosing, titration, injection, administration or treatment guidance. Questions about prescription medicines belong with a licensed prescriber and appropriately licensed pharmacy.
What GLP-1 means
GLP-1 stands for glucagon-like peptide-1, a naturally occurring hormone involved in several physiological processes. The phrase GLP-1 product is often used broadly online, but products can differ in active ingredient, receptor activity, formulation, approval status, source and evidence.
Some approved prescription medicines act on the GLP-1 receptor. Other compounds act on multiple targets or remain investigational. Grouping them together for navigation does not make them equivalent or interchangeable.
Approval is product-specific
FDA approval applies to a particular product, manufacturer, active ingredient, formulation, strength, route, indication and labeling. It does not automatically apply to a compounded version, a research listing, a different salt form, an imitation or a product that merely uses the same compound name.
| Product description | What it does—and does not—establish |
|---|---|
| FDA-approved prescription drug | Reviewed for the approved product and labeled conditions of use; approval does not transfer to unrelated versions |
| Generic drug | FDA-approved under the relevant pathway and evaluated for requirements including therapeutic equivalence |
| Compounded drug | Prepared for an identified patient need under applicable law; not FDA-approved |
| Investigational compound | Being studied; investigation is not approval or proof of safety and effectiveness |
| Research-use listing | A commercial label or intended-use statement; it does not make unlawful consumer drug marketing lawful |
FDA context for unapproved and compounded GLP-1 products
The FDA states that unapproved versions do not undergo its review for safety, effectiveness and quality before marketing. It advises patients to obtain prescriptions from their doctor and fill them at a state-licensed pharmacy. The agency also explains that compounded drugs are not the same as FDA-approved generic drugs.
In its current GLP-1 information, FDA identifies concerns including fraudulent labeling, dosing errors, use of certain salt forms, adverse-event reports and improper shipping temperatures. It also states that retatrutide and cagrilintide cannot be used in compounding under federal law and have not been found safe and effective for any condition.
Read the current primary source directly: FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss.
Red flags when reviewing an online listing
- The listing implies an unapproved or compounded item is the same as an FDA-approved product.
- A prescription drug is offered without appropriate screening and a prescription.
- The actual compounder or dispensing pharmacy is not identified where it should be.
- The label contains inconsistent names, spelling, addresses, quantities or instructions.
- The packaging is damaged, unsealed or materially different from what was represented.
- The seller provides consumer dosing instructions for an item presented as research use only.
- A purity report is used as a substitute for licensed dispensing, approval or clinical evidence.
Names, strengths and formulations
Read the complete active-ingredient name and formulation. Similar names, salt forms or attached components can represent different chemical materials. Confirm whether the displayed number refers to total container content, concentration, number of units or another measurement. Never infer administration instructions from a commercial quantity.
Storage and cold-chain questions
Storage is product-specific. FDA-approved injectable GLP-1 drugs have package-insert requirements, and FDA has warned that improper storage during shipping can create quality concerns for compounded injectable products. Follow the official labeling for an approved medicine or the product-specific documentation from the licensed dispensing source. Do not substitute a generic internet rule.
If a temperature-sensitive product arrives warm, inadequately protected, damaged or outside its documented conditions, do not guess whether it remains suitable. Retain the package, record the condition and contact the responsible licensed pharmacy, healthcare professional or seller as appropriate.
COAs and product identity
An analytical report may provide information about a submitted sample, but it does not show that an online seller is a licensed pharmacy, that a product was dispensed under a valid prescription, that shipping conditions were maintained, or that the item is equivalent to an approved drug. Match any report to the product and lot, then read the test limitations.
Questions to ask before relying on a claim
- Is the claim about an FDA-approved product, a compounded drug, an investigational compound or a research listing?
- Does the evidence study the same active ingredient, formulation and context?
- Is the seller implying equivalence that has not been established?
- Are the source, label, lot, storage conditions and documentation clear?
- Does the claim accurately describe the level of evidence without guaranteeing an outcome?
- Would the question be better directed to a licensed prescriber or pharmacy?
For patients and consumers
For prescription treatment, speak with a licensed healthcare professional who can consider health history, contraindications, interactions and monitoring. Use a properly licensed pharmacy and consult FDA’s BeSafeRx resources when evaluating online sources.
Is a compounded GLP-1 drug FDA-approved?
No. FDA states that compounded drugs are not FDA-approved and do not undergo the agency’s premarket review for safety, effectiveness and quality.
Is a compounded drug the same as a generic drug?
No. FDA-approved generics and compounded drugs follow different legal and regulatory pathways.
Does a COA make an online product equivalent to an approved medicine?
No. Analytical testing does not establish approval, licensed dispensing, clinical equivalence or appropriate use.
Can this site recommend a dose or titration schedule?
No. We do not provide prescribing, dosing, titration or administration guidance.